Apellis Pharmaceuticals Inc (APLS)
NASDAQ:APLS
Holding APLS?
Track your performance easily

Apellis Pharmaceuticals (APLS) Similar Stocks

848 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Apellis Pharmaceuticals
$3.58B
-14.72
-35.33%
12 Buy
5 Hold
0 Sell
Moderate Buy
Alnylam Pharma
$35.11B
-105.84
71.37%
18 Buy
6 Hold
0 Sell
Strong Buy
BioMarin Pharmaceutical
$12.76B
40.38
-19.89%
20 Buy
7 Hold
0 Sell
Moderate Buy
Crispr Therapeutics AG
$4.43B
-18.28
0.70%
8 Buy
6 Hold
2 Sell
Moderate Buy
Intellia Therapeutics
$1.63B
-3.07
-32.97%
16 Buy
4 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
APLS
Apellis Pharmaceuticals
29.98
-17.01
-36.20%
ALNY
Alnylam Pharma
277.43
115.54
71.37%
BMRN
BioMarin Pharmaceutical
67.07
-16.91
-20.14%
CRSP
Crispr Therapeutics AG
51.62
-1.54
-2.90%
NTLA
Intellia Therapeutics
16.73
-7.40
-30.67%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis